Position in RVMD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$331,298
+$7,748 QoQ
Shares Held
1,769
-46.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#478
of 687 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avior Wealth Management, LLC holds $5,109,937 across 10 Biotechnology names. RVMD ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,045 | $1,512,542 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,358 | $846,767 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
5,440 | $604,003 | |
| 4 | INSM |
INSMED Inc
|
4,913 | $523,824 | |
| 5 | ABVX |
Abivax S.A.
|
3,037 | $404,710 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
5,744 | $333,898 | |
| 7 | RVMD |
Revolution Medicines, Inc.
This page
|
1,769 | $331,298 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
3,780 | $308,334 |
All Filings in RVMD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $331,298 | 1,769 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $323,550 | 3,327 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $583,436 | 7,325 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $396,856 | 8,498 | Shares | Sole | 2025-11-14 | |
| 2024-03-31 | $870 | 27 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||